Journal Article Review Epublish 20 citations
PubMed: 38399223 DOI: 10.3390/pharmaceutics16020162
An Overview of Biofilm-Associated Infections and the Role of Phytochemicals and Nanomaterials in Their Control and Prevention.
Pharmaceutics 16(2)
Authors: Tsvetozara Damyanova, Petya D Dimitrova, Dayana Borisova, Tanya Topouzova-Hristova, Emi Haladjova, Tsvetelina Paunova-Krasteva
Affiliations
- Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Akad. G. Bonchev St. bl. 26, 1113 Sofia, Bulgaria.
- Faculty of Biology, Sofia University "St. K. Ohridski", 8 D. Tsankov Blvd. 1164 Sofia, Bulgaria.
- Institute of Polymers, Bulgarian Academy of Sciences, Akad. G. Bonchev St. bl. 103-A, 1113 Sofia, Bulgaria.
Abstract
Biofilm formation is considered one of the primary virulence mechanisms in Gram-positive and Gram-negative pathogenic species, particularly those responsible for chronic infections and promoting bacterial survival within the host. In recent years, there has been a growing interest in discovering new compounds capable of inhibiting biofilm formation. This is considered a promising antivirulence strategy that could potentially overcome antibiotic resistance issues. Effective antibiofilm agents should possess distinctive properties. They should be structurally unique, enable easy entry into cells, influence quorum sensing signaling, and synergize with other antibacterial agents. Many of these properties are found in both natural systems that are isolated from plants and in synthetic systems like nanoparticles and nanocomposites. In this review, we discuss the clinical nature of biofilm-associated infections and some of the mechanisms associated with their antibiotic tolerance. We focus on the advantages and efficacy of various natural and synthetic compounds as a new therapeutic approach to control bacterial biofilms and address multidrug resistance in bacteria.
MeSH
Infections, Bacteria, Phytochemicals, Biofilms, Nanostructures, Virulence
Cited by
- Multiple Strategies for the Application of Medicinal Plant-Derived Bioactive Compounds in Controlling Microbial Biofilm and Virulence Properties. Antibiotics (Basel), 2025
- Non-antibiotic therapies for multidrug-resistant gastrointestinal infections: an overview of the use of probiotics, natural compounds, and bacteriophages. Front Antibiot, 2025
- In Vitro Evaluation of the Antibacterial Effect and Influence on the Bacterial Biofilm Formation of Glutamic Acid and Some Structural Analogues. Antibiotics (Basel), 2025
- Gram Negative Biofilms: Structural and Functional Responses to Destruction by Antibiotic-Loaded Mixed Polymeric Micelles. Microorganisms, 2025
- The Effect of Quercetin Loading in Polylactic Acid-Based Electrospun Fibers on Their Antioxidant, Antibacterial and Antitumor Properties. Molecules, 2025
- Cationic Polymer Micelles as Carriers of Bioactive Sesquiterpene Lactones from Inula Helenium L. for Effective Treatment of Bacterial Biofilms. Pharmaceutics, 2025
- Phytochemical Characterization and Anti-Biofilm Activity of L. Roots. Molecules, 2025
- L. as biofilm inhibitor: Insights into the mechanism of action using proteomics/metabolomics and toxicity studies. Biofilm, 2025
- Infectious Aortitis Following Peripheral Angiographic Catheterization. Cureus, 2025
- Development and optimization of a novel nanocarrier SabiWhite-loaded ethosomal gel for targeted skin inflammation complicated by multidrug-resistant pathogens. Front Cell Infect Microbiol, 2025